Frankfurt - Delayed Quote • EUR Achieve Life Sciences, Inc. (SP4P.F) Follow Compare 3.0450 +0.0150 +(0.50%) At close: January 31 at 8:06:30 AM GMT+1 Comparisons Indicators Technicals Corporate events Line Candle Baseline Mountain Bar Step Baseline Delta HLC Wave Scatterplot Histogram Range Channel Colored Line Colored Mountain Colored Step Colored Bar Colored HLC Volume Candle Hollow Candle Step Mountain Verex Line Vertex Step Vertex Mountain Vertex Baseline Delta Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favourites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading chart for SP4P.F 1D 5D 9.14% 1M -14.59% 3M -26.00% 6M -31.65% YTD -14.59% 1Y -32.33% 5Y -70.14% All -99.51% Date range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours 1 day 1 week 1 month 3 months Recent news: SP4P.F View more All News Press releases SEC filings All SEC filings Corporate changes and voting matters Periodic financial reports Proxy statements Tender offer/acquisition reports Offering registrations Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory ACHV: Long-Term Exposure Requirement Complete Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1? Institutional shareholders may be less affected by Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) pullback last week after a year of 0.5% returns Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA Achieve Life Sciences Announces Participation at Upcoming Investor Conferences ACHV: Commercialization in Focus